ASX:PKS

Stock Analysis Report

Executive Summary

PKS Holdings Limited, a healthcare technology company, develops and commercializes proprietary subscription based clinical decision support (CDS) systems that automates the human decision-making process in healthcare organizations in Australia and internationally.

Snowflake

Fundamentals

High growth potential with adequate balance sheet.

Share Price & News

How has PKS Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

2.7%

PKS

-0.07%

AU Healthcare Services

0.7%

AU Market


1 Year Return

n/a

PKS

121.2%

AU Healthcare Services

11.0%

AU Market

Return vs Industry: Insufficient data to determine how PKS performed against the Australian Healthcare Services industry.

Return vs Market: Insufficient data to determine how PKS performed against the Australian Market.


Shareholder returns

PKSIndustryMarket
7 Day2.7%-0.07%0.7%
30 Day2.7%8.5%-0.2%
90 Day-9.5%9.7%-0.1%
1 Yearn/a122.2%121.2%17.4%11.0%
3 Yearn/a41.2%38.2%36.3%18.0%
5 Yearn/a483.1%431.2%51.4%17.3%

Price Volatility Vs. Market

How volatile is PKS Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is PKS Holdings undervalued compared to its fair value and its price relative to the market?

1.14x

Price to Book (PB) ratio


Share Price vs. Fair Value

Undervalued: Insufficient data to calculate PKS's fair value to establish if it is undervalued.

Significantly Undervalued: Insufficient data to calculate PKS's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: PKS is unprofitable, so we can't compare its PE Ratio to the Healthcare Services industry average.

PE vs Market: PKS is unprofitable, so we can't compare its PE Ratio to the Australian market.


Price to Earnings Growth Ratio

Low PEG Ratio: Insufficient data to calculate PKS's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: PKS is good value based on its PB Ratio (1.1x) compared to the AU Healthcare Services industry average (8.3x).


Next Steps

Future Growth

How is PKS Holdings forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

51.7%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: PKS is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.3%).

Earnings vs Market: PKS is forecast to become profitable over the next 3 year, which is considered above average market growth.

High Growth Earnings: PKS's loss is forecast to worsen by 0% next year.

Revenue vs Market: PKS's revenue (38.3% per year) is forecast to grow faster than the Australian market (3.6% per year).

High Growth Revenue: PKS's revenue (38.3% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

High Future ROE: PKS's Return on Equity is forecast to be low in 3 years time (12.7%).


Next Steps

Past Performance

How has PKS Holdings performed over the past 5 years?

-159.2%

Last years earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: PKS is unprofitable, and there is insufficient past data to establish if their past 5-year earnings growth rate was positive.

Accelerating Growth: Unable to compare PKS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: PKS is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (6.3%).


Return on Equity

High ROE: PKS has a negative Return on Equity (-4.62%), as it is currently unprofitable.


Return on Assets

ROA vs Industry: PKS is currently unprofitable, so its Return on Assets is negative.


Return on Capital Employed

ROCE Improving: PKS is currently unprofitable, so its Return on Capital Employed is negative.


Next Steps

Financial Health

How is PKS Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: PKS's short term assets (A$5.3M) exceeds its short term liabilities (A$975.1K)

Long Term Liabilities: PKS's short term assets (5.3M) exceeds its long term liabilities (25.6K)


Debt to Equity History and Analysis

Debt Level: PKS is debt free.

Reducing Debt: PKS has not had any debt for past 5 years.


Balance Sheet

Inventory Level: PKS has a low level of unsold assets or inventory.

Debt Coverage by Assets: Insufficient data to determine if PKS's debt is covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Insufficient data to determine if PKS has enough cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if PKS has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Next Steps

Dividend

What is PKS Holdings's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%2.5%markettop25%5.6%industryaverage1.0%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate PKS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate PKS's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if PKS's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if PKS's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of PKS's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.


Next Steps

Management

What is the CEO of PKS Holdings's salary, the management and board of directors tenure and is there insider trading?


CEO

PKS Holdings has no CEO, or we have no data on them.


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

SellAU$477,55223 Sep 19
Perennial Value Management Limited
EntityCompany
Shares2,458,988
Max PriceAU$0.19
BuyAU$244,70803 Sep 19
Bombora Investment Management Pty Ltd
EntityCompany
Shares1,385,000
Max PriceAU$0.19
BuyAU$282,85903 Sep 19
Perennial Value Management Limited
EntityCompany
Shares1,573,853
Max PriceAU$0.18
BuyAU$1,346,56501 Jul 19
Perennial Value Management Limited
EntityCompany
Shares6,824,048
Max PriceAU$0.20

Ownership Breakdown


Management Team


    Board Members

      Company Information

      PKS Holdings Limited's company bio, employee growth, exchange listings and data sources


      Key Information

      • Name: PKS Holdings Limited
      • Ticker: PKS
      • Exchange: ASX
      • Founded: 1996
      • Industry: Health Care Technology
      • Sector: Healthcare
      • Market Cap: AU$22.411m
      • Shares outstanding: 121.14m
      • Website: https://www.pks.com.au

      Number of Employees


      Location

      • PKS Holdings Limited
      • 126 Phillip Street
      • Level 5
      • Sydney
      • New South Wales
      • 2000
      • Australia

      Listings

      TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
      PKSASX (Australian Securities Exchange)YesOrdinary SharesAUAUDJun 2019
      PKSCHIA (Chi-X Australia)YesOrdinary SharesAUAUDJun 2019

      Biography

      PKS Holdings Limited, a healthcare technology company, develops and commercializes proprietary subscription based clinical decision support (CDS) systems that automates the human decision-making process in ...


      Company Analysis and Financial Data Status

      All financial data provided by Standard & Poor's Capital IQ.
      DataLast Updated (UTC time)
      Company Analysis2019/10/16 10:42
      End of Day Share Price2019/10/16 00:00
      Earnings2019/06/30
      Annual Earnings2019/06/30


      Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.